Exodus Point Capital Management, LP Qiagen N.V. Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$39.13 - $47.24 $1.99 Million - $2.41 Million	50,941 Added 25.97%	247,069 $10 Million
Q2 2023 Aug 10, 2023	BUY	$43.93 - $46.76 $8.62 Million - $9.17 Million	196,128 New	196,128 $8.83 Million
Q3 2022 Nov 10, 2022	SELL	$40.9 - $50.42 $1.24 Million - $1.53 Million	-30,275 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$42.98 - $49.77 $1.3 Million - $1.51 Million	30,275 New	30,275 $1.43 Million
Q1 2021 May 17, 2021	SELL	$46.25 - $56.02 $4.13 Million - $5 Million	-89,228 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $4.11 Million - $4.88 Million	89,228 New	89,228 $4.72 Million
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $409,945 - $460,501	-10,381 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.17 - $41.6 $344,337 - $431,849	10,381 New	10,381 $432,000
Q4 2019 Feb 14, 2020	SELL	$25.41 - $43.1 $630,396 - $1.07 Million	-24,809 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.73 - $40.81 $628,710 - $783,919	19,209 Added 343.02%	24,809 $818,000
Q2 2019 Aug 14, 2019	BUY	$35.73 - $41.39 $200,087 - $231,784	5,600 New	5,600 $227,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.36B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.